Data as of Aug 29
| +0.10 / +0.27%|
The 2 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 40.00, with a high estimate of 43.00 and a low estimate of 37.00. The median estimate represents a +9.68% increase from the last price of 36.47.
The current consensus among 2 polled investment analysts is to Buy stock in Cantel Medical Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.